ArdorComm Media Group

Thursday, April 2, 2026 11:10 PM

Health & Wellness Community

AIIMS Bhubaneswar Successfully Tests Drones for Healthcare Delivery in Odisha

AIIMS Bhubaneswar achieved a significant milestone on January 23 by successfully conducting an experimental trial utilizing drones to enhance healthcare services in Odisha. The unmanned aerial vehicle covered a remarkable distance of 120 km from AIIMS Bhubaneswar to the Community Health Centre in Tangi in just 1.10 hours, marking a groundbreaking advancement in medical logistics. The drones were specifically designed to transport essential blood supplies, weighing approximately 2 kg, with the entire journey executed seamlessly, showcasing the potential for integrating drone technology into the healthcare system. AIIMS Bhubaneswar Director, Ashutosh Biswas, expressed his satisfaction with the trial, emphasizing the commitment of the national institute to develop a model that seamlessly integrates technology to supplement existing logistics methods. Director Biswas highlighted the significance of this technology in bolstering healthcare services in remote, tribal, and semi-urban areas. Drones have the capacity to transport a variety of medical supplies, including vaccines, essential drugs, and diagnostic samples. This successful trial by AIIMS Bhubaneswar, a leading tertiary healthcare provider, opens new possibilities for enhancing healthcare accessibility for the people of Odisha. In an exclusive statement to ANI, Director Biswas stated, “Induction of drone delivery can boost the healthcare services in rural, tribal, and semi-urban locations. These drones can carry multiple health products, including vaccines, essential drugs, and diagnostic samples. AIIMS Bhubaneswar, as a leading tertiary healthcare provider, has created this opportunity for the people of Odisha.” The successful integration of drones in healthcare delivery marks a transformative step towards more efficient and timely medical services in challenging terrains and remote regions.

AIIMS Bhubaneswar Successfully Tests Drones for Healthcare Delivery in Odisha Read More »

India Witnesses Third COVID-19 Wave, Officials Confirm JN.1 Variant Impact

As India grapples with the ongoing challenges posed by the COVID-19 pandemic, official sources have confirmed the emergence of the JN.1 variant. However, reassuringly, the available data suggests that this variant is not causing an exponential rise in new cases, nor is it associated with a surge in hospitalizations and mortality rates. India has experienced three distinct waves of COVID-19, with the most significant impact observed during the Delta wave in April-June 2021. At its peak, the country reported a staggering 4,14,188 (4.14 lakh) new cases and 3,915 deaths on May 7, 2021. The latest data indicates that the JN.1 variant is not leading to a scenario similar to the Delta wave peak. This information comes as a relief amid concerns about the potential impact of new variants on the country’s healthcare system. Since the onset of the pandemic in early 2020, India has witnessed more than 4.50 crore people contracting the virus, with over 5.30 lakh fatalities recorded over the course of about four years. This underscores the persisting challenges and the need for ongoing efforts to combat the spread of the virus and mitigate its impact on public health. As the situation continues to evolve, health authorities are closely monitoring the spread and characteristics of the JN.1 variant. The confirmation that the variant is not currently associated with a severe increase in cases provides valuable insights for public health strategies.

India Witnesses Third COVID-19 Wave, Officials Confirm JN.1 Variant Impact Read More »

Pharma Industry’s Wishlist for Budget 2024: R&D Incentives and Policy Boost

In anticipation of Budget 2024, the Indian pharmaceutical industry is making a strong plea for fiscal incentives to foster research and development (R&D). With aspirations to reach a market size of USD 400-450 billion by 2047, the sector emphasizes the need for continuous investments in R&D, citing high risk, a long gestation period, and low success rates. Sudarshan Jain, the Secretary General of the Indian Pharmaceutical Alliance, urged for the upcoming budget to outline conducive policies, offering benefits in terms of both direct and indirect taxes while facilitating ease of doing business for pharmaceutical companies. The industry, set to achieve USD 120-130 billion by 2030, seeks accelerated innovation and R&D to realize its ambitious growth targets. The Promotion of Research & Innovation Program (PRIP) Scheme, introduced in 2023, was acknowledged as a positive step towards spurring innovation in the sector. Healthcare industry body NATHEALTH is advocating for increased healthcare spending to 2.5% of GDP and the rationalization of the GST framework. They aim to enhance the medical value travel segment, address MAT credit issues, and strengthen the healthcare value chain. Budget 2024 should prioritize building local capabilities for healthcare services, even in remote regions, and localize the healthcare value chain. Expectations include a roadmap for long-term infrastructure financing, an increase in medical and nursing colleges, and fiscal reforms in the health insurance sector, according to Narayana Health Executive Vice Chairman Viren Shetty. Metropolis Healthcare MD Ameera Shah seeks a zero per cent GST on diagnostic services and refunds for GST paid on inputs. With 60% of India’s diagnostics reliant on imports, Roche Diagnostics India MD Rishabh Gupta emphasizes the need for rationalizing import tariffs on healthcare products. The overarching goal is to prioritize affordable and accurate diagnostics, transforming India’s healthcare system for the better. Reference is taken from Economic times

Pharma Industry’s Wishlist for Budget 2024: R&D Incentives and Policy Boost Read More »

Chinese Health Authorities Warn of Potential COVID-19 Rebound in January

Chinese health authorities have issued a warning of a possible rebound in COVID-19 infections in January, despite a recent decline in patients at fever clinics since New Year’s Day. The National Health Commission spokesperson, Mi Feng, stated at a press briefing that while respiratory diseases, mainly influenza, are still prevalent, the COVID-19 infection rate remains relatively low. Recent data from the multi-channel monitoring system revealed a positive rate of COVID-19 testing below one percent in sentinel hospitals after the New Year’s Day holiday. Wang Dayan, director of the China National Influenza Center, expressed concern about the upward trend in the proportion of the JN.1 variant strain, indicating a potential resurgence. Experts anticipate a co-circulation of respiratory pathogens during the winter and spring, with influenza viruses dominating in the short term. Wang Dayan highlighted the potential for a COVID-19 rebound in January due to the continuous importation of the JN.1 variant, declining influenza, and a decrease in population immunity. The JN.1 variant is likely to become the dominant strain in China. Influenza B virus proportions have risen significantly in both southern and northern provinces, surpassing influenza A in some regions. Wang emphasized the need for early influenza vaccination, as the immune response from contracting influenza A does not protect against influenza B. Wang Guiqiang, director of the Department of Infectious Diseases at Peking University First Hospital, emphasized the peak season for respiratory infectious diseases in winter and the potential for repeated infections. He urged increased attention to early intervention and diagnosis, particularly for the elderly and those with underlying diseases, as COVID-19 or influenza infections could worsen underlying conditions.

Chinese Health Authorities Warn of Potential COVID-19 Rebound in January Read More »

Budget 2024: Pharma Industry Urges More Tax Breaks for R&D, Innovation, and Increased Healthcare Spending

Amidst the anticipation surrounding the upcoming Union Budget on February 1, the healthcare and pharmaceutical industry has outlined a comprehensive wishlist for Budget 2024, aiming for policies that foster innovation, research and development (R&D), and increased healthcare spending. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, emphasized the need for conducive policies that offer direct and indirect tax benefits to pharmaceutical companies. The focus should be on critical areas such as innovation, R&D, and upgrading healthcare infrastructure. Jain highlighted the significance of continuous investments, especially in a sector with high risks and long gestation periods. Dr. Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare & President of NATHEALTH, called for a significant hike in healthcare spending to 2.5% of GDP. The proposals presented by NATHEALTH emphasize transformative changes to bridge regional healthcare disparities and strengthen the healthcare value chain. The aim is to enhance medical value travel, address MAT credit issues, and build local capabilities for healthcare services. Ameera Shah, Promoter and Managing Director of Metropolis Healthcare, underscored the importance of the upcoming budget in strengthening India’s healthcare ecosystem. Shah advocated for investments in critical areas like innovation, research, development, technology, and upgrading healthcare infrastructure. Additionally, she called for a 0% GST on diagnostic services, GST refunds on inputs, and rationalizing import tariffs on healthcare products to enhance accessibility and affordability. These recommendations collectively aim to position India as a reliable supplier of medicines and a custodian of global healthcare. The healthcare sector looks forward to policy stability, continuity, and transformative measures in the upcoming budget, recognizing the role it plays in combating present and future healthcare challenges. Source: CNBC-TV18

Budget 2024: Pharma Industry Urges More Tax Breaks for R&D, Innovation, and Increased Healthcare Spending Read More »

Union Health Minister Unveils Ambitious ‘One District One Medical College’ Initiative for Comprehensive Healthcare in India

Union Health Minister Mansukh Mandaviya announced on Sunday that the government has initiated a new education policy inspired by Mahatma Gandhi’s principles. As part of this policy, the government aims to establish one medical college in each district across India, converting them into “Ayushman” districts. The minister made this announcement while speaking at the diamond jubilee celebration of Mahatma Gandhi Memorial Medical College in Indore. The event also saw the inauguration of a Central Drugs Standard Control Organisation (CDSCO) sub-zonal office and Central Drug Testing Laboratory (CDTL) in Indore. The minister also laid the foundation stone for various facilities at AIIMS, Bhopal and inaugurated several other health facilities in Madhya Pradesh. In his address, Mandaviya emphasized the government’s commitment to ensuring access to high-quality medicines for citizens and promoting ease of doing business for stakeholders in the pharmaceutical industry. He also highlighted the importance of the newly inaugurated facilities in AIIMS, Bhopal and the government’s goal of establishing AIIMS in all states of the country. The minister also stressed the significant role that medical colleges play in monitoring public health in their respective districts. He reminded the audience that the government’s goal of eradicating diseases like TB, kala-azar, and leprosy by 2025 relies heavily on the efforts of these medical colleges. The occasion also witnessed the inauguration of the Mahatma Gandhi Memorial Medical College alumni network and the release of a postal stamp and diamond jubilee souvenir of the institute. This initiative aims to strengthen the bond between the institute and its alumni and celebrate the legacy of Mahatma Gandhi. The news of the government’s plan to establish one medical college in each district in India has been met with enthusiasm and support from various sectors. This move will not only increase access to quality healthcare but also create a robust system for monitoring public health in the country. With this step, the government reaffirms its commitment to making India a healthier nation.

Union Health Minister Unveils Ambitious ‘One District One Medical College’ Initiative for Comprehensive Healthcare in India Read More »

Himachal Pradesh CM Sukhvinder Singh Sukhu Pioneers AI Integration in State’s Health Services

Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu has announced the state’s commitment to harnessing modern technology and Artificial Intelligence (AI) to fortify health services. Sukhu revealed that the government is considering the establishment of an AI ministry, making Himachal Pradesh the first state in India to embark on such an ambitious initiative. During a meeting of the health department in Shimla on Monday, CM Sukhu emphasized the state government’s extensive efforts to integrate AI across various sectors. He disclosed plans for the establishment of a National Cancer Centre in Hamirpur, aiming to utilize AI in diagnostics, surgery, radiotherapy, medical oncology, palliative care, preventive oncology, and molecular oncology. The ambitious project will also feature a world-class diagnostic lab equipped with cutting-edge technology. CM Sukhu has urged Union Health Minister Mansukh Mandavia to prioritize the establishment of a State Cancer Institute at Dr Radhakrishnan Government Medical College, Hamirpur, under the National Programme for Prevention and Control of Cancer, Diabetes, CBD, and Strokes. Additionally, he has sought support for the creation of a Super Specialty Block at the same medical college. In a move towards efficient governance, CM Sukhu recently launched the country’s first Report Management Portal (RMP) and Meeting Management Portal (MMP). These portals aim to streamline communication, decision-making processes, and data management within the government, providing real-time data access, SMS and email capabilities, and automatic reminders. However, amidst these technological advancements, Sukhu has accused the previous Jairam Thakur-led BJP government of financial mismanagement, alleging a ruinous impact on the state’s financial health. Distributing Rs. 9.88 crore as the first installment for the rehabilitation of disaster-affected families, Sukhu criticized the BJP government’s ‘double engine government’ slogan and claimed a substantial loan of 14 thousand crores in the fiscal year 2022-2023. He highlighted the state’s challenging financial position, marked by expenses surpassing income and a depleted treasury, while also pointing out alleged irregularities during the BJP’s rule, including the sale of competitive exam papers.

Himachal Pradesh CM Sukhvinder Singh Sukhu Pioneers AI Integration in State’s Health Services Read More »

India Ranks Second in Asian Cancer Burden, Lancet Report Highlights Alarming Trends

India has been identified as the second-highest contributor to cancer cases and deaths in Asia, with a recent Lancet report shedding light on the alarming statistics. The study, conducted by an international team of researchers, disclosed that India recorded around 12 lakh new cancer cases and 9.3 lakh deaths in 2019, solidifying its position as a significant player in the Asian disease burden landscape. China topped the list with a staggering 48 lakh new cases and 27 lakh deaths, while Japan followed with approximately nine lakh new cases and 4.4 lakh deaths. Tracheal, bronchus, and lung (TBL) cancer emerged as the predominant cancer type in Asia, contributing to an estimated 13 lakh cases and 12 lakh deaths. The report highlighted the elevated risk of cervical cancer among women in several Asian countries and underscored the effectiveness of the human papillomavirus (HPV) vaccine in preventing the disease and lowering associated mortality rates. Risk factors such as smoking, alcohol consumption, and ambient particulate matter (PM) pollution were identified as major contributors to the rising cancer burden in Asia. The researchers expressed concern over the escalating cancer rates linked to increasing air pollution in the region, driven by industry-led economic growth, urbanization, rural-to-urban migration, and a surge in motor vehicle use. Of notable concern was the prevalence of smokeless tobacco (SMT) in South Asian countries like India, Bangladesh, and Nepal. Products such as khaini, gutkha, betel quid, and paan masala were identified as significant contributors to lip and oral cavity cancer cases and deaths. The study emphasized the urgency of prioritizing timely cancer screening and treatment availability, particularly in low- and medium-income Asian countries where oncologic infrastructure is often lacking or unaffordable, especially in rural areas. Addressing these challenges, the report suggested, is crucial for improving survival rates and overall cancer outcomes in the region.

India Ranks Second in Asian Cancer Burden, Lancet Report Highlights Alarming Trends Read More »

Healthcare Tech Firm HealthEC LLC Faces Massive Data Breach Affecting 4.5 Million Patients

HealthEC LLC, a leading provider of health management solutions, has fallen victim to a significant data breach, potentially compromising the sensitive information of approximately 4.5 million patients. The breach occurred between July 14 and 23, 2023, but the company only disclosed the incident on December 22. The compromised data includes a range of personal and medical information, such as names, addresses, dates of birth, Social Security numbers, medical records, and health insurance details. The breach also exposed billing and claims information, including patient account numbers and treatment cost details. HealthEC’s population health management platform, used by healthcare organizations for data integration, analytics, and care coordination, suffered unauthorized access during the cyberattack. The investigation into the breach concluded on October 24, 2023, confirming the theft of files containing sensitive information. HealthEC urges affected individuals to remain vigilant against identity theft and fraud by regularly reviewing account statements and monitoring free credit reports for suspicious activity. While HealthEC initially refrained from specifying the number of affected individuals, a recent submission to Maine’s Attorney General’s office revealed that one of the firm’s clients, MD Valuecare, accounted for 112,005 affected persons. However, a new listing on the U.S. Department of Health and Human Services’ breach portal indicates that the total number of impacted individuals is a staggering 4,452,782. Seventeen healthcare service providers and state-level health systems have been identified as victims of this cyberattack on HealthEC. Notable organizations impacted include Corewell Health, HonorHealth, Beaumont ACO, State of Tennessee – Division of TennCare, the University Medical Center of Princeton Physicians’ Organization, and the Alliance for Integrated Care of New York. HealthEC advises affected individuals to promptly report any suspicious activity to relevant parties, such as insurance companies, healthcare providers, and financial institutions. This incident underscores the escalating threat to healthcare data security, emphasizing the critical need for robust cybersecurity measures in the healthcare technology sector.

Healthcare Tech Firm HealthEC LLC Faces Massive Data Breach Affecting 4.5 Million Patients Read More »

California Expands Healthcare Coverage for Low-Income Immigrants Amidst Budget Deficit Concerns

California is set to provide free healthcare to over seven lakh immigrants, regardless of their immigration status, starting this New Year. The ambitious expansion is part of the Democrats’ broader goal to achieve universal healthcare coverage for the state’s approximately 39 million residents. This initiative, spearheaded by Democratic Governor Gavin Newsom, will cost the state an estimated $3.1 billion annually. The expansion marks a significant milestone, making California the most populous state to guarantee such extensive coverage. Oregon had initiated a similar program in July, but California’s scale surpasses that effort. The move is a result of a 2022 agreement between Governor Newsom and lawmakers to extend healthcare access through the state’s Medicaid program, Medi-Cal, to all low-income adults, irrespective of their immigration status. Advocates argue that this expansion will bridge gaps in healthcare access and eventually save the state money, as individuals without legal status often delay or avoid care, leading to costlier emergency room treatments. However, as the program kicks off, California faces a daunting $68 billion budget deficit, raising concerns about the economic implications of the expansion. Republican Senator Roger Niello questions the decision, emphasizing the impact on the state’s deficit. Critics worry that the expansion could strain the already burdened healthcare system and highlight the high costs associated with the move. The estimated annual cost of $3.1 billion adds to the state’s substantial Medicaid program expenses, which currently stand at around $37 billion annually. Despite the challenges, advocates view this expansion as a crucial step toward comprehensive care. Dr. Efrain Talamantes of AltaMed in Los Angeles, the largest federally qualified health center in California, sees it as a “win-win” situation that will contribute to community health. While California faces hurdles such as a record budget deficit and ongoing Medicaid eligibility reviews, healthcare advocates emphasize the need to reach out to a historically excluded population. Fear and distrust, stemming from concerns about the “public charge” rule, may pose challenges, but the broader goal of achieving “universal coverage” remains a driving force. The expansion represents California’s most significant healthcare initiative since the implementation of the Affordable Care Act in 2014. Despite financial constraints, the state aims to prioritize the health of its residents, particularly those who have long been excluded from the healthcare system.

California Expands Healthcare Coverage for Low-Income Immigrants Amidst Budget Deficit Concerns Read More »